INFLUENCE OF LANSOPRAZOLE TREATMENT ON DIAZEPAM PLASMA-CONCENTRATIONS

被引:63
作者
LEFEBVRE, RA
FLOUVAT, B
KAROLACTAMISIER, S
MOERMAN, E
VANGANSE, E
机构
[1] ROUSSEL UCLAF,BRUSSELS,BELGIUM
[2] A PARE HOSP,TOXICOL & PHARMACOKINET LAB,BOULOGNE BILLANCO,FRANCE
关键词
D O I
10.1038/clpt.1992.172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The possible influence of long-term treatment with lansoprazole on the single-dose pharmacokinetics of diazepam was investigated in 12 healthy male volunteers. In this double-blind randomized crossover study, 60 mg lansoprazole or placebo was administered once daily for 10 days. One hour after administration on day 7, 0.1 mg/kg diazepam was administered intravenously, and blood was collected up to 96 hours after the injection for plasma diazepam and desmethyldiazepam measurement. During the placebo session, the plasma elimination half-life, clearance, and volume of distribution of diazepam were 26.0 +/-1.6 hours, 22.5 +/- 1.1 ml/hr/kg, and 0.82 +/- 0.04 L/kg, respectively. These parameters were not significantly different during the lansoprazole session. The mean plasma concentrations of desmethyldiazepam were similar in both sessions. These findings illustrate that long-term treatment with a therapeutic dose of lansoprazole does not interfere with the metabolism of diazepam.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 22 条
[1]   EFFECT OF OMEPRAZOLE AND CIMETIDINE ON PLASMA DIAZEPAM LEVELS [J].
ANDERSSON, T ;
ANDREN, K ;
CEDERBERG, C ;
EDVARDSSON, G ;
HEGGELUND, A ;
LUNDBORG, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (01) :51-54
[2]   EFFECT OF OMEPRAZOLE TREATMENT ON DIAZEPAM PLASMA-LEVELS IN SLOW VERSUS NORMAL RAPID METABOLIZERS OF OMEPRAZOLE [J].
ANDERSSON, T ;
CEDERBERG, C ;
EDVARDSSON, G ;
HEGGELUND, A ;
LUNDBORG, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :79-85
[3]   OMEPRAZOLE DRUG-INTERACTION STUDIES [J].
ANDERSSON, T .
CLINICAL PHARMACOKINETICS, 1991, 21 (03) :195-212
[4]  
BARDHAN K O, 1991, Gastroenterology, V100, pA30
[5]   IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].
BERTILSSON, L ;
HENTHORN, TK ;
SANZ, E ;
TYBRING, G ;
SAWE, J ;
VILLEN, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355
[6]  
DELHOTAL B, 1992, J PHARM CLIN-SERIES, P242
[7]  
DELHOTALLANDES B, 1991, 4TH P EUR C BIOPH PH, P315
[8]  
DELHOTALLANDES B, 1992, J CHROMATOGR, V577, P117
[9]   OMEPRAZOLE INHIBITS OXIDATIVE DRUG-METABOLISM - STUDIES WITH DIAZEPAM AND PHENYTOIN INVIVO AND 7-ETHOXYCOUMARIN INVITRO [J].
GUGLER, R ;
JENSEN, JC .
GASTROENTEROLOGY, 1985, 89 (06) :1235-1241
[10]  
HANAUER G, 1991, METHOD FIND EXP CLIN, V13, P63